A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane.

Trial Profile

A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Mar 2016

At a glance

  • Drugs Ixabepilone (Primary) ; Capecitabine
  • Indications Advanced breast cancer
  • Focus Adverse reactions
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 05 Feb 2010 Actual end date changed from Oct 2009 to Jan 2010 as reported by ClinicalTrials.gov.
    • 09 Dec 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
    • 09 Dec 2009 Actual patient number (9) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top